Back to top
more

Zimmer Biomet Holdings, Inc. (ZBH)

(Real Time Quote from BATS)

$138.36 USD

138.36
83,685

-0.15 (-0.11%)

Updated Oct 18, 2019 09:54 AM ET

Add to portfolio

4-Sell       4  

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1
2
3
4
5
S&P
Strong Buy
Buy
Hold
Sell
Strong Sell
500
24.50%
17.69%
9.28%
4.86%
1.63%
10.50%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

C Value | C Growth | B Momentum | C VGM

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

View All Zacks #1 Ranked Stocks

Trades from $1

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Zacks News

Zacks Equity Research

Here's Why You Should Hold Zimmer Biomet (ZBH) Stock for Now

Investor confidence continues to be high in Zimmer Biomet (ZBH), thanks to solid prospects.

HAE MDT ZBH AMED

Zacks Equity Research

Align Technology Inks Distribution Deal With Zimmer Biomet

This deal indicates Align Technology's (ALGN) commitment to strengthen its portfolio of iTero scanner and services.

BAX ZBH HAE ALGN

Zacks Equity Research

Zimmer Biomet's New JuggerStitch to Grow Sports Medicine Line

Zimmer Biomet's (ZBH) JuggerStitch claims to offer a less invasive, all-suture, knotless approach to meniscal repair procedures.

ZBH GWPH BAX NTRP

Zacks Equity Research

Zimmer Biomet (ZBH) Launches Persona Revision for Knee Care

Zimmer Biomet (ZBH) prepares for the commercial launch of improvised knee replacement procedures through its flagship program, Persona Revision Knee System.

GWPH ZBH BAX NTRP

Zacks Equity Research

Zimmer Biomet Succeeds in Priority Areas, Suffers Pricing Woe

With regard to product suite, Zimmer Biomet (ZBH) steadily wins an array of key regulatory clearances for knee, brain and spine applications under its ROSA platform over the past several months.

MDT ZBH NUVA BAX

Zacks Equity Research

Why Is Zimmer (ZBH) Up 7.9% Since Last Earnings Report?

Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ZBH

Zacks Equity Research

ZBH vs. MDT: Which Stock Should Value Investors Buy Now?

ZBH vs. MDT: Which Stock Is the Better Value Option?

ZBH MDT

Zacks Equity Research

Zimmer Biomet Wins Nod for Spinal Teather to Treat Scoliosis

Zimmer Biomet's (ZBH) AVBT solution, The Tether, uses a solid, flexible cord in place of traditional metal rods to pull on the outside of a scoliosis curve.

BAX MDT NUVA ZBH

Zacks Equity Research

BioScrip Closes Option Care Merger, Incurs Wider Q2 Loss

With the conclusion of BioScrip (BIOS)-Option Care consolidation, the newly formed company gets its new name Option Care Health, Inc. under the ticker symbol BIOS.

SRDX BAX ZBH BIOS

Zacks Equity Research

Orthofix Medical (OFIX) Beats on Q2 Earnings, Margins Down

Orthofix Medical's (OFIX) Q2 performance across all business segments has been commendable, except for spinal implants.

SRDX ZBH OFIX BAX

Zacks Equity Research

Zimmer Biomet (ZBH) Beats on Q2 Earnings, Narrows '19 View

Zimmer Biomet (ZBH) observes strength in the Asia Pacific and EMEA regions as well as in the S.E.T. business.

TFX HOLX ZBH XRAY

Zacks Equity Research

Zimmer Biomet (ZBH) Q2 Earnings and Revenues Beat Estimates

Zimmer (ZBH) delivered earnings and revenue surprises of 0.52% and 0.34%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

ZBH

Zacks Equity Research

ZBH vs. MDT: Which Stock Should Value Investors Buy Now?

ZBH vs. MDT: Which Stock Is the Better Value Option?

ZBH MDT

Zacks Equity Research

Why Earnings Season Could Be Great for Zimmer Biomet (ZBH)

Zimmer Biomet (ZBH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

ZBH

Zacks Equity Research

Can New Product Menu Aid Zimmer Biomet's (ZBH) Q2 Earnings?

With consecutive product approvals, Zimmer Biomet (ZBH) becomes the first company on the global frontier with 510(k) clearance for Brain, Spine and Knee offerings on a single robotic platform.

TMO SYK ZBH XRAY

Zacks Equity Research

Zimmer Biomet (ZBH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zimmer (ZBH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ZBH

Zacks Equity Research

Zimmer Biomet Grows Internationally Despite Pricing Pressure

Zimmer Biomet (ZBH) witnesses strength in the EMEA and APAC regions as well as in the Spine & CMF business.

CERN BRKR PEN ZBH

Zacks Equity Research

Why Is Zimmer (ZBH) Down 8.2% Since Last Earnings Report?

Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ZBH

Urmimala Biswas

Zimmer Biomet's (ZBH) Q1 Earnings, Revenues Beat Estimates

While sales in Americas remains dull, Zimmer Biomet (ZBH) is witnessing strength in the Asia Pacific and EMEA regions.

ABT SYK ZBH CNMD

Zacks Equity Research

Will Pricing Pressure Hurt Zimmer Biomet (ZBH) Q1 Earnings?

With Zimmer Biomet (ZBH) focusing solely on this restructuring initiative, chances are slim for the company to post promising growth performances across its operating segments.

ZBH NSTG EOLS ACB

Zacks Equity Research

Earnings Preview: Zimmer Biomet (ZBH) Q1 Earnings Expected to Decline

Zimmer (ZBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ZBH

Zacks Equity Research

Zimmer Biomet's FDA 510(k) Nod Widens Robotic Offerings

With the FDA nod, Zimmer Biomet (ZBH) attains the status of being the first company to boast the 510(k) clearance for Brain, Spine and Knee offerings on a single robotic platform globally.

VEEV ITGR HOLX ZBH

Zacks Equity Research

Zimmer Biomet Solid on Global Prospects Despite Price Pressure

Zimmer Biomet (ZBH) has been working to strengthen foothold in emerging markets. However, the company has been facing continued pricing pressure.

VEEV HOLX ITGR ZBH

Zacks Equity Research

RTI Surgical Buys Paradigm Spine, Adds Coflex to Portfolio

RTI Surgical's (RTIX) acquisition of Paradigm Spine aligns with the former's goal of expanding its spine portfolio.

ISRG RTIX SYK ZBH

Zacks Equity Research

Zimmer Biomet (ZBH) Jumps: Stock Rises 6.4%

Zimmer Biomet (ZBH) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

ZBH APYX